Recbio and Rongsheng Biotech Collaborate for Adjuvant Vaccine

Recbio and Rongsheng Biotech collaborate over a new Adjuvant Vaccine Project in China

Overview

Two Chinease firms, Jiangsu Recbio Technology Co., Ltd. and Shanghai Rongsheng Biotech Co.,Ltd. have partnered to lead a new adjuvant vaccine research and development project in Shanghai. The partnership fecilitates for the joint developmet of new adjuvant vaccines.

Post Agrrement

• The two parties signed a strategic cooperation agreement on the new adjuvant vaccine project. 
• Recbio will provide its new adjuvant independently developed based on the new adjuvant technology platform.
• Rongsheng Biotech will provide its independently designed viral antigen. This project will empower existing Rongsheng Biotech vaccines under development with new adjuvants to improve immunogenicity and optimize the vaccination program.

Words from Recbio

Dr. Liu Yong, founder, chairman of the board and general manager of Recbio, said: "This cooperation is an important milestone for Recbio adjuvants to empower industry chain partners. New adjuvant play a crucial role in the development and application of innovative vaccines. Relying on its independently developed new adjuvant technology platform."

Words from Rongsheng Biotech

Zhu Shaorong, founder and chairman of Rongsheng Biotech, said: "Rongsheng Biotech has built a key core technology platform for 'virus + bacteria 'vaccines based on independent innovation and research and development. It has large-scale production capabilities and has achieved technological innovation and upgrade breakthroughs in scientific research on a number of vaccine products under development.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!